{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:32:06Z","timestamp":1761741126721,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T00:00:00Z","timestamp":1584057600000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2020]]},"DOI":"10.6061\/clinics\/2020\/e1530","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T10:19:46Z","timestamp":1586945986000},"page":"e1530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Intracoronary Sarcoplasmic Reticulum Calcium-ATPase Gene Therapy in Advanced Heart Failure Patients with reduced Ejection Fraction: A Prospective Cohort Study"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8004-035X","authenticated-orcid":false,"given":"Jianfeng","family":"Zhang","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3511-7482","authenticated-orcid":false,"given":"Guojin","family":"Hu","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2625-6296","authenticated-orcid":false,"given":"Shengyong","family":"Yang","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"3","key":"10.6061\/clinics\/2020\/e1530_bib1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/CIRCGENETICS.114.000687","article-title":"MicroRNA therapy for the failing heart","volume":"7","author":"Martinez-Fernandez","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"10.6061\/clinics\/2020\/e1530_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.12703\/P5-27","article-title":"AAV-mediated gene therapy for heart failure: enhancing contractility and calcium handling","volume":"5","author":"Zouein","year":"2013","journal-title":"F1000Prime Rep"},{"issue":"1","key":"10.6061\/clinics\/2020\/e1530_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/CIRCRESAHA.113.302421","article-title":"Long-term effects of AAV1\/SERCA2a gene transfer in patients with severe heart failure: analysis of recurrent cardiovascular events and mortality","volume":"114","author":"Zsebo","year":"2014","journal-title":"Circ Res"},{"issue":"7","key":"10.6061\/clinics\/2020\/e1530_bib4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jacc.2012.03.067","article-title":"Contemporary evidence about hospital strategies for reducing 30-day readmissions: a national study","volume":"60","author":"Bradley","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.6061\/clinics\/2020\/e1530_bib5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/cvr\/cvv008","article-title":"TNF-\u03b1 down-regulates sarcoplasmic reticulum Ca2? ATPase expression and leads to left ventricular diastolic dysfunction through binding of NF-\u03baB to promoter response element","volume":"105","author":"Tsai","year":"2015","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.6061\/clinics\/2020\/e1530_bib6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jchf.2013.09.008","article-title":"Design of a phase 2b trial of intracoronary administration of AAV1\/SERCA2a in patients with advanced heart failure: the CUPID 2 trial (calcium up-regulation by percutaneous administration of gene therapy in cardiac disease phase 2b)","volume":"2","author":"Greenberg","year":"2014","journal-title":"JACC Heart Fail"},{"issue":"12","key":"10.6061\/clinics\/2020\/e1530_bib7","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrcardio.2012.145","article-title":"Altered sarcoplasmic reticulum calcium cycling\u2013targets for heart failure therapy","volume":"9","author":"Kho","year":"2012","journal-title":"Nat Rev Cardiol"},{"issue":"8","key":"10.6061\/clinics\/2020\/e1530_bib8","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1161\/CIRCRESAHA.113.302187","article-title":"Sarcoplasmic reticulum Ca-ATPase and heart failure 20 years later","volume":"113","author":"Eisner","year":"2013","journal-title":"Circ Res"},{"issue":"10024","key":"10.6061\/clinics\/2020\/e1530_bib9","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0140-6736(16)00082-9","article-title":"Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial","volume":"387","author":"Greenberg","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.6061\/clinics\/2020\/e1530_bib10","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.111.022889","article-title":"Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure","volume":"124","author":"Jessup","year":"2011","journal-title":"Circulation"},{"issue":"27","key":"10.6061\/clinics\/2020\/e1530_bib11","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"issue":"6","key":"10.6061\/clinics\/2020\/e1530_bib12","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1161\/CIRCHEARTFAILURE.113.000359","article-title":"Comparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction","volume":"6","author":"Joseph","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"19","key":"10.6061\/clinics\/2020\/e1530_bib13","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.jacc.2007.09.008","volume":"50","author":"Cooper","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 1","key":"10.6061\/clinics\/2020\/e1530_bib14","first-page":"173","article-title":"The Study of Chloramphenicol for Ophthalmic Formulation","volume":"7","author":"Ashara","year":"2018","journal-title":"IJSRR"},{"issue":"7","key":"10.6061\/clinics\/2020\/e1530_bib15","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jacc.2012.03.066","article-title":"Hospital strategies to reduce heart failure readmissions: where is the evidence?","volume":"60","author":"Butler","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.6061\/clinics\/2020\/e1530_bib16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/eurjhf\/hfq234","article-title":"Augmentation of left ventricular mechanics by recirculation-mediated AAV2\/1-SERCA2a gene delivery in experimental heart failure","volume":"13","author":"Mariani","year":"2011","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.6061\/clinics\/2020\/e1530_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/CIRCOUTCOMES.110.957225","article-title":"Lifetime costs of medical care after heart failure diagnosis","volume":"4","author":"Dunlay","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"7","key":"10.6061\/clinics\/2020\/e1530_bib18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/jgm.2885","article-title":"Intramyocardial injection of SERCA2a-expressing lentivirus improves myocardial function in doxorubicin-induced heart failure","volume":"18","author":"Mattila","year":"2016","journal-title":"J Gene Med"},{"issue":"7","key":"10.6061\/clinics\/2020\/e1530_bib19","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/mt.2010.77","article-title":"SERCA2a gene transfer enhances eNOS expression and activity in endothelial cells","volume":"18","author":"Hadri","year":"2010","journal-title":"Mol Ther"},{"issue":"10","key":"10.6061\/clinics\/2020\/e1530_bib20","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/clc.22468","article-title":"Correlation of the New York Heart Association Classification and the 6-Minute Walk Distance: A Systematic Review","volume":"38","author":"Yap","year":"2015","journal-title":"Clin Cardiol"},{"issue":"6","key":"10.6061\/clinics\/2020\/e1530_bib21","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/mt.2008.89","article-title":"SERCA2a gene therapy for heart failure: ready for primetime?","volume":"16","author":"Periasamy","year":"2008","journal-title":"Mol Ther"},{"issue":"11","key":"10.6061\/clinics\/2020\/e1530_bib22","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.jacc.2007.12.014","article-title":"Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure","volume":"51","author":"Kawase","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.6061\/clinics\/2020\/e1530_bib23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijcard.2011.01.014","article-title":"Expression of B-type natriuretic peptide forms in ischemic human hearts","volume":"158","author":"Cort\u00e9s","year":"2012","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.6061\/clinics\/2020\/e1530_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejphar.2011.09.012","article-title":"Acute myocardial ischemia directly modulates the expression of brain natriuretic peptide at the transcriptional and translational levels via inflammatory cytokines","volume":"670","author":"Xia","year":"2011","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.6061\/clinics\/2020\/e1530_bib25","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1001\/jamapediatrics.2018.4954","article-title":"Incidence of Hospitalization for Vaccine-Preventable Infections in Children Following Solid Organ Transplant and Associated Morbidity, Mortality, and Costs","volume":"173","author":"Feldman","year":"2019","journal-title":"JAMA Pediatr"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222003052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222003052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:53:19Z","timestamp":1761720799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222003052"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1807-59322020000100220&lng=en&nrm=iso","label":"SCIELO"},{"URL":"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7061318\/","label":"PMC"},{"URL":"https:\/\/www.clinicsjournal.com\/article\/intracoronary-sarcoplasmic-reticulum-calcium-atpase-gene-therapy-in-advanced-heart-failure-patients-with-reduced-ejection-fraction-a-prospective-cohort-study\/","label":"CLINICS"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":25,"alternative-id":["S1807593222003052"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2020\/e1530","relation":{},"ISSN":["1807-5932"],"issn-type":[{"type":"print","value":"1807-5932"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intracoronary Sarcoplasmic Reticulum Calcium-ATPase Gene Therapy in Advanced Heart Failure Patients with reduced Ejection Fraction: A Prospective Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2020\/e1530","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}],"article-number":"e1530"}}